AzTrials
AzTrials

ArthroplastyCORI RCT TKANCT04848896

Study to Evaluate the Safety and Effectiveness of the REAL INTELLIGENCE™ CORI™ in Total Knee Arthroplasty (TKA) Procedure

A study testing CORI Robotics and Conventional Procedure in people with Arthroplasty and Replacement, run by Smith & Nephew, Inc. at 4 sites in 4 countries.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Background: REAL INTELLIGENCE™ CORI™ (CORI Robotics) is a computer-assisted orthopaedic surgical navigation and burring system. CORI Robotics is designed to help surgeons in planning and executing certain types of knee surgery involving bone preparation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Arthroplasty, Replacement, Knee
What is being tested?
CORI Robotics and Conventional Procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
4 sitesin 4 countries
Study dates
12 Feb 2022to 2 Jul 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subject is a suitable candidate for a TKA procedure using CORI and a corresponding S+N Knee Implant System.
  • Subject requires a cemented TKA as a primary indication that meets any of the following condition:
  • Non-inflammatory degenerative joint disease, including osteoarthritis
  • Rheumatoid arthritis
  • Avascular necrosis
  • Requires correction of functional deformity
Show all 11Show fewer
  • Requires treatment of fractures that were unmanageable using other techniques
  • Subject is of legal age to consent and considered skeletally mature (≥ 18 years of age at the time of surgery)
  • Subject agrees to consent to and to follow the study visit schedule (as defined in the study protocol and informed consent form), by signing the Ethical Committee (EC) or Institutional Review Board (IRB) approved informed consent form.
  • Subject plans to be available through two (2) year postoperative follow-up.
  • Applicable routine radiographic assessment is possible.

Who cannot join

  • Subject requires a TKA on the index joint as a revision for a previously failed surgery, or has the need for complex implants, or any other implant than a standard TKA (e.g. stems, augments, or custom-made devices).
  • Subject has been diagnosed with post-traumatic arthritis.
  • Subject receives simultaneous bilateral UKA OR a unilateral UKA with contralateral TKA.
  • Subject has one or more of the following arthroplasties that are not fully healed and well-functioning, as determined by the investigator:-Contralateral primary TKA or UKA, however, the subject can only have one knee enrolled in this study.
  • Subject does not understand the language used in the Informed Consent Form.
  • Subject does not meet the indication or is contraindicated for TKA according to the specific Smith+Nephew Knee System's Instructions For Use (IFU).
Show all 15Show fewer
  • Subject has active infection or sepsis (treated or untreated).
  • Subject is morbidly obese with a body mass index (BMI) greater than 40.
  • Subject is pregnant or breast feeding at the time of surgery.
  • Subject, in the opinion of the Investigator, has advanced osteoarthritis or joint disease at the time of surgery and was better suited for an alternate procedure.
  • Subject currently enrolled in another orthopedic clinical trial study.
  • Subject has a condition(s) that may interfere with the TKA survival or outcome (i.e., Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease, or an active, local infection).
  • Subject in the opinion of the Investigator has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, intellectual disability, drug or alcohol abuse.
  • Subject, in the opinion of the Investigator, has a neuromuscular disorder that prohibited control of the index joint.
  • Subject is a prisoner or meets the definition of a Vulnerable Subject per International Organization for Standardization (ISO) 14155:2020 Section 3.55.

Trial locations and contacts

4 sites in 4 countries.

4 sites in 4 countries

Australia1 site
  • Northern Hospital

    Epping, 3076

Other trials in Australia

China1 site
  • Jishuitan Hospital, Beijing

    Beijing, 100035

Other trials in China

Hong Kong1 site
  • The Prince of Wales Hospital

    Shatin

Other trials in Hong Kong

New Zealand1 site
  • North Shore Hospital

    Auckland, 0620

Other trials in New Zealand

About this study

Official title: A Prospective, Multi-center, Randomized Controlled Study to Evaluate the Safety and Effectiveness of REAL INTELLIGENCE™ CORI™ in Total Knee Arthroplasty (TKA) Procedure

Background:

REAL INTELLIGENCE™ CORI™ (CORI Robotics) is a computer-assisted orthopaedic surgical navigation and burring system. CORI Robotics is designed to help surgeons in planning and executing certain types of knee surgery involving bone preparation. These types of surgery are called 'unicondylar knee arthroplasty' (UKA) and 'total knee arthroplasty' (TKA).

Read more

Purpose:

This study is being carried out to demonstrate the safety and effectiveness of the CORI Robotics in TKA procedure. The data collected will be used to demonstrate the safety and effectiveness of CORI and to register CORI in China mainland. The primary objective of this study is to evaluate the use of CORI in TKA procedure in achieving post-operative leg alignment as compared to procedures using conventional manual instruments.

Research participants / locations:

80 research participants will be recruited from up to 8 sites in 3 countries globally (Australia, China Mainland, Hong Kong and New Zealand). There will be roughly 40 patients having TKA using CORI and 40 patients having TKA using conventional procedure.

Being tested
CORI Robotics, Conventional Procedure
Keywords
Osteoarthritis, Total Knee Arthroplasty (TKA)
Medical subject headings
Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CORI RoboticsDevice

    Total knee arthroplasty (TKA) treated with CORI Robotics System.

  • Conventional ProcedureProcedure or surgery

    Total knee arthroplasty (TKA) treated with conventional approach with conventional manual instrumentation.

Study groups in NCT04848896
Study groupRoleWhat they receive
CORIExperimentalSubjects in need for total knee arthroplasty (TKA) as decided by their doctor and treated with CORI Robotics System.
Receives: Device: CORI Robotics
Conventional ProcedureActive comparatorSubjects in need for total knee arthroplasty (TKA) as decided by their doctor and treated with conventional approach with conventional manual instrumentation.
Receives: Procedure: Conventional Procedure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post-operative Leg Alignment

    Post-operative leg alignment via radiographic assessment. Post-operative leg alignment is achieved when the deviation from the subject specific target does not exceed ±3 degrees.

    Measured: 6 weeks

Secondary outcomes (6)
  1. Component Alignment

    Component alignment will be assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery

    Measured: 6 weeks

  2. Radiographic Assessment

    Radiographic assessment on antero-posterior (A/P) and lateral (L) views shall be performed to identify the presence of radiolucent lines, osteolysis \& implant migration.

    Measured: 12 months and 24 months

  3. 2011 Knee Society Score (KSS)

    The Functional Knee Score is derived from assessments of walking and standing, standard activities, advanced activities, and discretionary activities in TKA subjects. The 2011 Knee Society Score consists of 4 separate subscales:

    1. An "Objective" Knee Score (seven items: 100 points)
    2. A Patient Satisfaction Score (five items: 40 points)
    3. A Patient Expectation Score (three items: 15 points)
    4. A Functional Activity Score (19 items: 100 points).

    A higher number is a better outcome.

    Measured: Pre-op, 6 weeks, 6 months, 12 months and 24 months

  4. Oxford Knee Score (OKS)

    To specifically assess the patient's perspective of outcome following knee arthroplasty surgery in TKA subjects. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.

    Measured: Pre-op, 6 weeks, 6 months, 12 months and 24 months

  5. Forgotten Joint Score (FJS)

    To assess joint-specific patient reported outcomes in TKA subjects. Responses to 12 questions are recorded with a five point Likert response format: "Never", "almost never", "seldom", "sometimes" and "mostly". The item scores are summed and linearly transformed in a 0 to 100 scale and then reversed with a high value reflecting the ability of the subject to forget about the replaced knee joint during the activities of daily living. A score of 100 is the best possible outcome.

    Measured: 6 weeks, 6 months, 12 months and 24 months

  6. EuroQol Five-Dimensional Five-Level (EQ-5D-5L)

    To assess the subject's health state in TKA subjects. The EQ-5D-5L is composed of the EQ-5D-5L descriptive system and the EQ Visual Analogue scale (EQ VAS). The descriptive system comprises 5 dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression). Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Responses are coded as single-digit numbers expressing the severity level selected in each dimension. For instance, 'slight problems' (e.g. 'I have slight problems in walking about') is always coded as '2'. The digits for the five dimensions are combined in a 5-digit code. The EQ- 5D-5L index value is derived by using the vendor supplied calculator to convert each 5-digit EQ-5D-5L profile. The EQ VAS corresponds to a 20 cm vertical, visual analogue scale ranging from 'the best health you can imagine' to 'the worst health you can imagine'. A higher number is a better outcome.

    Measured: Pre-op, 6 weeks, 6 months, 12 months and 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Apr 2021
  2. Study start12 Feb 2022
  3. Primary completion2 Jun 2026
  4. Study completion2 Jul 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04848896
Sponsor's protocol ID
CORI.2020.08
Acronym
CORI RCT TKA
Status last verified
Oct 2026
First submitted
7 Apr 2021
Last updated
3 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing CORI Robotics and Conventional Procedure in people with Arthroplasty and Replacement, run by Smith & Nephew, Inc. at 4 sites in 4 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 3 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Australia, China, Hong Kong, New Zealand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post-operative Leg Alignment (time frame: 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in